跳至主要内容
临床试验/IRCT20190921044831N1
IRCT20190921044831N1已完成3 期

Comparison of the effectiveness of oral Tizanidine in severity of pain after Septoplasty, in two groups of drug and placebo

Kermen Medical University, Chancel of research0 个研究点目标入组 71 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
71

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Patients with septoplasty class 1 or/and 2 ASA
  • Not history of gastric ulcer
  • Not history of using corticosteroids or other immune system suppressors

排除标准

  • Allergy to Tizanidine
  • Age < 18 y or >50 y
  • Re-Septoplasty
  • Sinorhinoplasty
  • Contraindication of Tizanidine therapy
  • Cases that need to be treated differently by anesthesia or surgery
  • Hepatic or renal disorder
  • Cases of ASA 3

研究者

发起方
Kermen Medical University, Chancel of research

相似试验